altimmune glp-1 9 Companies Developing Next-Generation Drugs Altimmune ($ALT): Best-in-Class Tolerability, One

doi: 10.1172/JCI84431 16 KieransSJTaylorCT

The published research literature has investigated: GHRH receptor activation in pituitary somatotroph cells Pulsatile release of endogenous growth hormone Subsequent IGF-1 elevation through downstream GH signaling Maintained natural feedback regulation through somatostatin and IGF-1 DPP-4-resistant pharmacokinetics from the trans-3-hexenoic acid modification The two compounds produce fundamentally different research effects: AOD-9604 produces lipolytic activity without affecting IGF-1 or broader GH-mediated signaling Tesamorelin produces full GH axis activation including IGF-1 elevation and broader GH-mediated effects Pharmacokinetic Comparison The compounds have different pharmacokinetic profiles: AOD-9604

10.3889/oamjms.2015.056 [DOI] [PMC free article] [PubMed] [Google Scholar] Shashirekha, M

iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM